Figure 1 shows the different distribution of plasma biomarkers in patients with normal and fast progression, with NfL being the only marker able to differentiate PD patients with different rates of motor change (32.0 ± 22.6 vs 20.1 ± 19.5; p = 0.007). This evidence concerns the gene NEFL and Parkinson disease.